vimarsana.com
Home
Live Updates
Effepharm Ltd: Effepharm's UTHEVER NMN: 66 people Human Clin
Effepharm Ltd: Effepharm's UTHEVER NMN: 66 people Human Clin
Effepharm Ltd: Effepharm's UTHEVER NMN: 66 people Human Clinical Trial Data Published, NAD+/NADH Level increased 38% in 2 months
Effepharm Ltd creatively launched a branded NMN ingredient to bring the purest and safest NMN ingredient around the world. UTHEVER NMN has been clinically proven to be safe and to improve the NAD+/NADH
Related Keywords
Japan ,
United States ,
United Kingdom ,
Kostenloser Wertpapierhandel ,
Kenay Agescience ,
Jianjun Yu ,
Effepharm Ltd ,
Harvard Medical School ,
Business Wire ,
Harvard Medical ,
Prohealth Longevity ,
Effepharm ,
Thever ,
People ,
Human ,
Linical ,
Trial ,
Data ,
Published ,
Madh ,
Level ,
Ncreased ,
Months ,